id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-N-2672-1737,FDA,FDA-2022-N-2672,FONSI for Amended EA for AAS,Other,Amendment,2024-10-02T04:00:00Z,2024,10,2024-10-02T04:00:00Z,,2024-10-02T15:08:05Z,,0,0,09000064867a673b
FDA-2022-N-2672-1738,FDA,FDA-2022-N-2672,Final Amended EA,Other,Amendment,2024-10-02T04:00:00Z,2024,10,2024-10-02T04:00:00Z,,2024-10-02T15:10:22Z,,0,0,09000064867a673d
FDA-2022-N-2672-1736,FDA,FDA-2022-N-2672,Draft Response to Public Comment on AAS Amended EA,Other,Response(s),2024-10-02T04:00:00Z,2024,10,2024-10-02T04:00:00Z,,2024-10-02T15:07:17Z,,0,0,09000064867a6739
FDA-2022-N-2672-1735,FDA,FDA-2022-N-2672,"Amended Environmental Assessment for Production of AquAdvantage Salmon at the Bay Fortune and Rollo
Bay Facilities on Prince Edward Island, Canada; Availability",Notice,Notice of Availability,2024-09-30T04:00:00Z,2024,9,,,2024-09-30T14:37:02Z,2024-22308,0,0,09000064867a0336
FDA-2022-N-2672-0009,FDA,FDA-2022-N-2672,"Transcript of CVM’s Virtual Public Meeting - Public Meeting on Draft Amended Environmental Assessment for Production of AquAdvantage Salmon at the Bay Fortune and Rollo Bay Facilities on Prince Edward Island, Canada",Other,Transcript(s),2023-01-09T05:00:00Z,2023,1,2023-01-09T05:00:00Z,,2023-01-09T20:31:26Z,,0,0,09000064855c8191
FDA-2022-N-2672-0004,FDA,FDA-2022-N-2672,Public Meeting: Draft Amended Environmental Assessment Concerning AquAdvantage Salmon,Other,Environmental assessment,2022-12-16T05:00:00Z,2022,12,2022-12-16T05:00:00Z,,2022-12-16T16:09:16Z,,0,0,0900006485534aea
FDA-2022-N-2672-0005,FDA,FDA-2022-N-2672,"Draft Amended Environmental Assessment for Production of AquAdvantage Salmon at the Bay Fortune and Rollo Bay Facilities on Prince Edward Island, Canada - Presentation",Other,Environmental assessment,2022-12-16T05:00:00Z,2022,12,2022-12-16T05:00:00Z,,2022-12-16T16:09:23Z,,0,0,0900006485534aec
FDA-2022-N-2672-0002,FDA,FDA-2022-N-2672,"Draft Amended Environmental Assessment for Production of AquAdvantage Salmon at the Bay Fortune and Rollo Bay Facilities on Prince Edward Island, Canada; Public Meeting; Request for Comments",Notice,Public Meetings,2022-11-17T05:00:00Z,2022,11,2022-11-17T05:00:00Z,2023-01-18T04:59:59Z,2023-01-24T02:01:08Z,2022-25002,0,0,09000064854bdfde
FDA-2022-N-2672-0003,FDA,FDA-2022-N-2672,"Draft Amended Environmental Assessment for Production of AquAdvantage Salmon at the Bay Fortune and Rollo Bay Facilities on Prince Edward Island, Canada; Availability; Request for Comments",Notice,Notice of Availability,2022-11-17T05:00:00Z,2022,11,2022-11-17T05:00:00Z,2023-01-18T04:59:59Z,2023-01-19T02:01:06Z,2022-25001,0,0,09000064854bdfe4
FDA-2022-N-2672-0001,FDA,FDA-2022-N-2672,"Draft Amended Environmental Assessment for Production of AquAdvantage® Salmon at the Bay Fortune and Rollo Bay Facilities on Prince Edward Island, Canada",Other,Assessment Document or Analysis,2022-11-16T05:00:00Z,2022,11,2022-11-16T05:00:00Z,,2022-11-16T17:45:01Z,,0,0,09000064854bb7e3